Fifty-three million doses of the Moderna vaccine have been administered to Americans. On Tuesday, March 16th Moderna announced that they will begin vaccine trials on children ages six months to 12 years old.
Moderna is set to enroll with 6,750 pediatric participants in the U.S and Canada. The study will be broken into two parts. Part one will test participants ages 2-12 years old, in two doses. Part two will test participants ages six months to two years old in one of three dose levels.
Children in the study will be followed for 12 months after their second vaccine dose. A similar trial was started by Moderna in December of 2020, with 3,000 children aged 12-18.
We project that high school students will very likely be able to be vaccinated by the fall term, maybe not the very first day, but certainly in the early part of the fall for that fall educational term. Elementary school kids, we’re doing this what’s called age de-escalation studies to make sure it’s safe and immunogenic in them. They likely will be able to get vaccinated by the very first quarter of 2022.
-Anthony Fauci
Related: How To Detoxify and Heal From Vaccinations – For Adults and Children
It has already been shown that children are not the primary spreaders of the coronavirus. Additionally, previous trials have shown that side effects for the vaccine are even more severe for younger people.